ARDX
Ardelyx, Inc.$5.97-0.02 (-0.33%)Prev Close$5.99·MCap$1.46B·P/E—·Vol1.23M·Yield—
▲
Buys (12M)
6
$7.30M
▼
Sells (12M)
41
$4.45M
◆
Net Activity
Net Buyer
$2.85M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Ardelyx, Inc. (ARDX) has been mixed between buying and selling, with 6 insider purchases totaling $7.30M and 41 insider sales totaling $4.45M. The most recent insider transaction was by RAAB MICHAEL (director, officer: President & CEO), who sold $262.0K worth of shares on Apr 17, 2026. Ardelyx, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.46B.
ARDX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $6.29 | $262.0K | 1,795,614 |
| Mar 18, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.84 | $243.3K | 1,816,448 |
| Feb 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.25 | $260.6K | 1,836,153 |
| Feb 23, 2026 | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026 | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 23, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,567 |
| Feb 23, 2026 | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,918 |
| Feb 23, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026 | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 20, 2026 | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
| Feb 20, 2026 | Reilly Joseph James | See Remarks | Sell | 4,989 | $5.85 | $29.2K | 0 |
| Feb 20, 2026 | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026 | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Feb 20, 2026 | RAAB MICHAEL | President & CEO | Sell | 45,979 | $5.85 | $268.8K | 0 |
| Feb 20, 2026 | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026 | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026 | Bishop John E | See Remarks | Sell | 3,178 | $5.85 | $18.6K | 0 |
| Feb 20, 2026 | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Jan 9, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026 | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025 | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025 | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025 | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
| Aug 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,841 | $5.93 | $34.6K | 0 |
| Aug 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 45,687 | $5.93 | $271.0K | 0 |
| Aug 21, 2025 | Renz Justin A | Chief Financial Officer | Sell | 7,037 | $5.93 | $41.7K | 0 |
| Aug 21, 2025 | Kelliher Mike | Chief Business Officer | Sell | 5,417 | $5.93 | $32.1K | 0 |
| Aug 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 15,308 | $5.93 | $90.8K | 0 |
| Aug 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,261 | $5.93 | $37.1K | 0 |
| Jun 16, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.63 | $725.9K | 0 |
| Jun 9, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.69 | $737.3K | 0 |
| May 20, 2025 | Williams Laura A | Chief Medical Officer | Sell | 6,421 | $4.08 | $26.2K | 0 |
| May 20, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,817 | $4.08 | $191.1K | 0 |
| May 20, 2025 | Kelliher Mike | See Remarks | Sell | 14,522 | $4.08 | $59.3K | 0 |
| May 20, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 2,507 | $4.08 | $10.2K | 0 |
| May 20, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,992 | $4.08 | $24.5K | 0 |
| May 20, 2025 | Renz Justin A | Chief Financial Officer | Sell | 7,218 | $4.08 | $29.5K | 0 |
| May 15, 2025 | MOTT DAVID M | Director | Buy | 100,000 | $3.29 | $329.1K | 0 |
| May 2, 2025 | MOTT DAVID M | Director | Buy | 381,377 | $4.22 | $1.61M | 0 |
| May 2, 2025 | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.25 | $177.2K | 0 |
| Apr 4, 2025 | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.59 | $191.2K | 0 |
| Mar 7, 2025 | RAAB MICHAEL | President & CEO | Sell | 41,668 | $5.36 | $223.2K | 0 |
| Feb 24, 2025 | MOTT DAVID M | Director | Buy | 77,729 | $5.00 | $388.7K | 0 |
Showing 1–50 of 228
1 / 5
ARDX Insider Buying Activity
The following table shows recent insider purchases of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,918 |
| Feb 20, 2026 | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
| Jun 16, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.63 | $725.9K | 0 |
| Jun 9, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.69 | $737.3K | 0 |
| May 15, 2025 | MOTT DAVID M | Director | Buy | 100,000 | $3.29 | $329.1K | 0 |
| May 2, 2025 | MOTT DAVID M | Director | Buy | 381,377 | $4.22 | $1.61M | 0 |
| Feb 24, 2025 | MOTT DAVID M | Director | Buy | 77,729 | $5.00 | $388.7K | 0 |
ARDX Insider Selling Activity
The following table shows recent insider sales of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $6.29 | $262.0K | 1,795,614 |
| Mar 18, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.84 | $243.3K | 1,816,448 |
| Feb 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.25 | $260.6K | 1,836,153 |
| Feb 23, 2026 | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026 | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 23, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,567 |
| Feb 23, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026 | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 20, 2026 | Reilly Joseph James | See Remarks | Sell | 4,989 | $5.85 | $29.2K | 0 |
| Feb 20, 2026 | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026 | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Feb 20, 2026 | RAAB MICHAEL | President & CEO | Sell | 45,979 | $5.85 | $268.8K | 0 |
| Feb 20, 2026 | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026 | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026 | Bishop John E | See Remarks | Sell | 3,178 | $5.85 | $18.6K | 0 |
| Feb 20, 2026 | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Jan 9, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026 | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025 | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025 | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025 | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
| Aug 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,841 | $5.93 | $34.6K | 0 |
| Aug 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 45,687 | $5.93 | $271.0K | 0 |
| Aug 21, 2025 | Renz Justin A | Chief Financial Officer | Sell | 7,037 | $5.93 | $41.7K | 0 |
| Aug 21, 2025 | Kelliher Mike | Chief Business Officer | Sell | 5,417 | $5.93 | $32.1K | 0 |
| Aug 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 15,308 | $5.93 | $90.8K | 0 |
| Aug 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,261 | $5.93 | $37.1K | 0 |
| May 20, 2025 | Williams Laura A | Chief Medical Officer | Sell | 6,421 | $4.08 | $26.2K | 0 |
| May 20, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,817 | $4.08 | $191.1K | 0 |
| May 20, 2025 | Kelliher Mike | See Remarks | Sell | 14,522 | $4.08 | $59.3K | 0 |
| May 20, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 2,507 | $4.08 | $10.2K | 0 |
| May 20, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,992 | $4.08 | $24.5K | 0 |
| May 20, 2025 | Renz Justin A | Chief Financial Officer | Sell | 7,218 | $4.08 | $29.5K | 0 |
| May 2, 2025 | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.25 | $177.2K | 0 |
| Apr 4, 2025 | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.59 | $191.2K | 0 |
| Mar 7, 2025 | RAAB MICHAEL | President & CEO | Sell | 41,668 | $5.36 | $223.2K | 0 |
ARDX Insiders
Similar Stocks to ARDX
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B